Trial Profile
A pharmacodynamic study of dimethylfumarate (DMF) in healthy voluneers and patients with relapsing-remitting multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 17 Nov 2016 New trial record